Finer Wealth Management’s AbbVie ABBV Stock Holding History

Finer Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$504K	Buy	2,318 +9	+0.4%	+$2K	0.25%	57
2025 Q4	$528K	Buy	2,309 +1,287	+126%	+$293K	0.26%	55
2025 Q3	$237K	Buy	+1,022	New	+$208K	0.12%	79
2025 Q2	–	Sell	-1,022	Closed	-$214K	–	87
2025 Q1	$214K	Buy	+1,022	New	+$199K	0.13%	79
2024 Q4	–	Sell	-1,025	Closed	-$202K	–	83
2024 Q3	$202K	Buy	+1,025	New	+$191K	0.12%	75

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Finer Wealth Management's ABBV Position: Q1 2026 in Review

Finer Wealth Management increased its AbbVie (ABBV) stake by 0.39% in Q1 2026, buying an estimated $2K and bringing the position to 2,318 shares worth $504K. The position accounts for 0.25% of the portfolio, ranked #57.

Finer Wealth Management first reported a position in ABBV in Q3 2024 and has held it in 5 quarters since. The position peaked at $528K in Q4 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Finer Wealth Management held 2,318 shares of AbbVie worth $504K as of Q1 2026.
Finer Wealth Management bought 9 AbbVie shares in Q1 2026, an estimated $2K.
AbbVie made up 0.25% of Finer Wealth Management's portfolio in Q1 2026, its #57 holding.
Finer Wealth Management first reported a position in AbbVie in Q3 2024 and has held it in 5 quarters since.
Finer Wealth Management's AbbVie position peaked at $528K in Q4 2025.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Finer Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.